ABT
Abbott Laboratories
NYSE: ABT · HEALTHCARE · MEDICAL DEVICES
$90.79
-0.59% today
Updated 2026-04-30
Market cap
$158.70B
P/E ratio
25.58
P/S ratio
3.52x
EPS (TTM)
$3.57
Dividend yield
2.60%
52W range
$90 – $136
Volume
11.9M
Abbott Laboratories (ABT) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $5.33B | $5.18B | $7.34B | $7.28B | $8.74B | $8.97B | $9.31B | $3.32B | $3.67B | $2.97B | $3.20B | $5.57B | $6.30B | $6.14B | $7.90B | $10.53B | $9.58B | $7.26B | $8.56B | $9.57B |
| Capital expenditures | $1.34B | $1.66B | $1.29B | $1.09B | $1.02B | $1.49B | $1.80B | $1.15B | $1.08B | $1.11B | $1.12B | $1.14B | $1.39B | $1.64B | $2.18B | $1.89B | $1.78B | $2.20B | $2.21B | $2.17B |
| Depreciation | $1.56B | $1.85B | $1.84B | $2.09B | $2.62B | $3.04B | $2.78B | $1.72B | $1.55B | $1.47B | $1.35B | $3.02B | $3.28B | $3.01B | $3.33B | $3.54B | $3.27B | $3.24B | $3.22B | — |
| Stock-based comp | $136.47M | $46.33M | $347.01M | $366.36M | $387.18M | $383.00M | $433.00M | $262.00M | $246.00M | $292.00M | $310.00M | $406.00M | $477.00M | $519.00M | $546.00M | $640.00M | $685.00M | $644.00M | $673.00M | $664.00M |
| Free cash flow | $3.99B | $3.53B | $6.06B | $6.19B | $7.72B | $7.48B | $7.52B | $2.18B | $2.60B | $1.86B | $2.08B | $4.43B | $4.91B | $4.50B | $5.72B | $8.65B | $7.80B | $5.06B | $6.35B | $7.39B |
| Investing cash flow | $-11.40B | $-1.14B | $-2.09B | $-3.70B | $-12.19B | $260.83M | $-6.08B | $-3.93B | $-202.00M | $406.00M | $-248.00M | $-9.62B | $-1.36B | $-1.81B | $-2.21B | $-2.01B | $-1.74B | $-3.13B | $-2.34B | — |
| Financing cash flow | $3.62B | $-2.31B | $-3.49B | $1.00B | $-1.09B | $-6.02B | $716.09M | $-6.70B | $-2.74B | $-2.24B | $11.15B | $-5.28B | $-10.39B | $-4.29B | $-2.78B | $-5.49B | $-7.64B | $-7.09B | $-5.40B | — |
| Dividends paid | $1.78B | $1.96B | $2.17B | $2.41B | $2.67B | $2.94B | $3.18B | $882.00M | $1.34B | $1.44B | $1.54B | $1.85B | $1.97B | $2.27B | $2.56B | $3.20B | $3.31B | $3.56B | $3.84B | $4.12B |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $4.70B | $-5.16B | $3.16B | $3.99B | $-7.33B | $588.00M | $938.00M | $13.62B | $-9.21B | $-5.45B | $32.00M | $2.91B | $3.03B | $205.00M | — | — | — |